Submitted by roany98@gmail.com on Mon, 07/17/2023 - 14:26
Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management (Faculty Presentations)
Hans Lee, MD
Associate Professor
Director, Multiple Myeloma Clinical Research
Department of Lymphoma/Myeloma
The University of Texas MD Anderson Cancer Center
Houston, Texas
Associate Professor
Director, Multiple Myeloma Clinical Research
Department of Lymphoma/Myeloma
The University of Texas MD Anderson Cancer Center
Houston, Texas
Saad Zafar Usmani, MD, MBA
Chief of Myeloma Service
Memorial Sloan Kettering Cancer Center
New York, New York